Pfizer Inc. PFE

NYSEHealth TechnologyUnited States

$28.89+0.06 (+0.21%)

Market closed· Nov 13, 2026, 9:01 PM UTC· USD · Data may be delayed

Day's range: 28.6228.99
52-week range: 23.6231.44

Financial health

– / 5

Analyst view · 28 firms

Hold8 buy · 17 hold · 3 sell

Avg. target $29.92 (+3.6%)

Prices may be delayed and are for informational purposes only - not investment advice.

Pfizer Inc. PFE

NYSEHealth TechnologyUnited States

$28.89+0.06 (+0.21%)

Market closed· Nov 13, 2026, 9:01 PM UTC· USD · Data may be delayed

Day's range: 28.6228.99
52-week range: 23.6231.44

Financial health

– / 5

Analyst view · 28 firms

Hold8 buy · 17 hold · 3 sell

Avg. target $29.92 (+3.6%)

Valuation from filings

Calculated from the tables below and the current price ($28.89) · LTM · 2026/9 · 2026-09-27

P/E: 41.27EPS $0.70
P/B: 1.86BV/share $15.54
P/S: 2.60Sales/share $11.11
Return on equity: 4.5%Net income / equity
Net margin: 6.3%Operating margin 26.1%
Free cash flow yield: 7.2%Free cash flow / market cap

Revenue and net income

Fiscal year · $ billions · net margin below

RevenueNet Income

Financial statements

$ millions · Under each value: change against a year earlier

Upgrade to MakklerPRO to see every row.Upgrade to MakklerPRO

Fiscal year	2021	2022	2023	2024	2025	LTM
Income Statement
Revenue	81,288	101,175+24%	59,553-41%	63,627+7%	62,579-2%	63,624
Cost of Revenue
Gross Profit
Operating Income
Pre-tax income
Income tax (expense) / benefit
Net Income	21,979	31,372+43%	2,119-93%	8,031+279%	7,771-3%	4,033
Earnings per share ($)
Margins
Gross margin
Operating margin
Net margin

Taken from the company's own 10-K and 10-Q filings via the SEC's XBRL data service. The "LTM" column is the last completed fiscal year plus the current year to date, minus the same period a year earlier. Lines a company tags with a non-standard label are left blank rather than filled with an approximation. Not investment advice.